NCT04840888View on ClinicalTrials.gov

A Study of LY3484356 in Healthy Female Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

82

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

April 12, 2022

Study Completion Date

April 12, 2022

Conditions

Healthy

Interventions

DRUG

LY3484356

Administered orally.

DRUG

Omeprazole

Administered orally.

DRUG

Itraconazole

Administered orally.

DRUG

Carbamazepine

Administered orally.

Trial Locations (2)

32117

LabCorp CRU, Inc., Daytona Beach

75247

Covance Dallas, Dallas

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY